A New Treatment for Metastatic Breast Cancer

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 115, Nº. 6, 2015, págs. 23-24
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * A new treatment is now available for postmenopausal women with estrogen receptor–positive, human epidermal growth factor receptor 2–negative metastatic breast cancer. Palbociclib (Ibrance) inhibits cyclin-dependent kinases 4 and 6.